Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
Dr. Caitlin McMullen and panelists Dr. Kedar Kirtane, Dr. Sarimar Agosto Salgado, and Barb Wampler, RN, discuss new therapies and clinical trial development in head and neck and…
Peter Attia, MD, joins MedCram to discuss the optimization of cancer screening using various techniques, including information on timing, imaging (full body MRI, etc), and liquid biopsies. Dr…
Brad Leibovich, MD, a urologic oncologist at Mayo Clinic, explains that kidney cancer in its early stages often presents no signs or symptoms and there is no screening…
